中国人群奥氮平稳态浓度个体间变异:代谢酶单核苷酸多态性探索
该研究分析北京安定医院310例奥氮平治疗患者的1002份血清浓度,探讨生理因素、吸烟、炎症、合并用药及CYP1A2、CYP3A5、UGT1A4、FMO1/3单核苷酸多态性对剂量调整浓度的影响。贝叶斯网络与g-computation显示吸烟、性别、舍曲林、当归龙荟丸和丙戊酸与奥氮平C/D比值存在因果关联,而所测SNP均未达显著水平。
要点
- 男性及吸烟分别使奥氮平C/D比值降低1.135和0.821。
- 舍曲林、当归龙荟丸和丙戊酸分别使C/D比值降低0.92427、1.134和0.832。
核心结论
- 性别、年龄、吸烟、炎症状态以及合并使用舍曲林、当归龙荟丸和丙戊酸均贡献奥氮平稳态浓度的个体间变异。
研究设计与样本
- 研究纳入北京安定医院310例奥氮平治疗患者,采用液相色谱-质谱法测定1002份血清浓度。
主要发现
- 贝叶斯网络提示吸烟、性别、舍曲林、当归龙荟丸、丙戊酸与奥氮平C/D比值存在因果关系。
- 所测SNP均未达到显著性水平。
- Wilcoxon符号秩检验证实多药联用和炎症状态均增加个体内C/D比值。
- g-computation显示男性使C/D比值降低1.135,吸烟降低0.821。
- 当归龙荟丸、舍曲林和丙戊酸分别使C/D比值降低1.134、0.92427和0.832。
临床怎么用
- 临床实践中应考虑性别、年龄、吸烟、炎症及合并使用舍曲林、当归龙荟丸和丙戊酸等因素,以帮助亚洲患者实现奥氮平个体化治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Olanzapine steady-state concentration can vary due to several factors. This study explores how physiological factors, smoking status, inflammation status, concomitant medications and metabolic enzyme single nucleotide polymorphisms (SNPs) influence its metabolic levels, aiming to guide personalized dosing. METHODS: This study analysed data from 310 olanzapine-treated patients at Beijing Anding Hospital. Liquid chromatography-mass spectrometry quantified 1002 serum concentrations. Eleven SNPs from CYP1A2, CYP3A5, UGT1A4 and FMO1/3 were identified through real-time fluorescence quantitative polymerase chain reaction. A Bayesian network was applied to elucidate causal relationships between variables, followed by g-computation to quantify the effect of individual factors on the dose-adjusted concentration (C/D ratio) of olanzapine. The Wilcoxon signed-rank test assessed the intraindividual variations in the steady-state C/D ratio. RESULTS: The Bayesian network suggested causality between smoking, sex, sertraline, Danggui-Longhui, valproic acid and the olanzapine C/D ratio. None of the SNPs reached significance levels. The Wilcoxon signed-rank test confirmed that both polypharmacy and inflammation increased the C/D ratio within individuals. G-computation showed that the olanzapine C/D ratio decreased by 1.135 in males and 0.821 with smoking. Danggui-Longhui, sertraline and valproic acid reduced the ratio by 1.134, 0.92427 and 0.832, respectively. CONCLUSION: Our study confirms that sex, age, smoking, inflammation and coprescription with sertraline, Danggui-Longhui and valproic acid contributed to variability in olanzapine's steady-state concentration. Considering these factors in clinical practice may help to personalize olanzapine treatment in Asian patients.
引用
- Wan Z, Zang YN, Jia F, et al. Interindividual variability in olanzapine steady-state concentrations in Chinese: exploring single nucleotide polymorphisms of metabolic enzymes. Br J Clin Pharmacol. 2025. PMID: 40625301. doi:10.1002/bcp.70161
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。